Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company manufactures pharmaceutical formulations catering to the anti-tuberculosis, antacids, paediatric, antibiotic, and veterinary segments.
Concept Pharmaceuticals Limited, is an unlisted public company incorporated on 20 March, 1979. It is classified as a public limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 16.00 cr and the total paid-up capital is INR 12.00 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
-19.57%
-28.39%
-57.82%
1.49%
10.89%
1.34%
1.57
-0.57
-1.3
-3.07
-2.75
0.02
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(12)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Canara Bank
No. of Loans: 2
Total Amount : 188.0 cr
Bank of Baroda
No. of Loans: 6
Total Amount : 8.0 cr
Dena Bank
No. of Loans: 6
Total Amount : 7.6 cr
OMAN INTERNATIONAL BANK
No. of Loans: 2
Total Amount : 5.9 cr
The Hongkong and Shanghai Banking Corporation Limited
No. of Loans: 1
Total Amount : 3.0 cr
Central Bank of India
No. of Loans: 1
Total Amount : 1.7 cr
THE STATE INDUSTRAIL AND INVESTMENTCORPORATION OF MAHARASTRA
No. of Loans: 1
Total Amount : 1.4 cr
BANK OF AMERICA
No. of Loans: 1
Total Amount : 1.0 cr
Punjab National Bank
No. of Loans: 3
Total Amount : 1.0 cr
BOMBAY MERCENTILE CO.OP. BANK LTD.
No. of Loans: 3
Total Amount : 0.6 cr
MAHARASTRA STATE FINANCIAL CORPORATION
No. of Loans: 2
Total Amount : 0.4 cr
THE SARASWAT CO.OPERATIVE BANK LTD.
No. of Loans: 3
Total Amount : 0.2 cr
THE NORTH KANARA CO.OP. BANK LTD.
No. of Loans: 1
Total Amount : 0.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Adhyatma Bandhu Gupta
Shareholder
|
00586777 | 40 years |
| Director | Yugin Adhyatma Gupta | 02365420 | 12 years |
| Director | Ved Parkash Kumar | 05138130 | 29 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| DYNAMIC MACHINES PRIVATE LIMITED |
Active
|
6.0 L | 1 | Maharashtra |
| ADHYATMA INVESTMENTS PRIVATE LIMITED |
Strike Off
|
1.1 L | 1 | Maharashtra |
| SANJANA HOLDINGS PVT LTD |
Active
|
1.0 L | 1 | Maharashtra |
| CONCEPT LABORATORIES PVT LTD |
Active
|
75.0 L | 1 | Maharashtra |
| KARLA INVESTMENT AND TRADING COMPANY PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| CONCEPT DISTRIBUTION PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| JOVIAL REALTORS PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| Y R FERROUS LLP |
Active
|
2.0 L | 1 | en |
| G Y HEALTHCARE LLP |
Active
|
1.0 L | 1 | Maharashtra |
The incorporation date of CONCEPT PHARMACEUTICALS LIMITED is 20 March, 1979
The authorized share capital of CONCEPT PHARMACEUTICALS LIMITED is INR ₹ 16.0 Cr.
The paid-up capital of CONCEPT PHARMACEUTICALS LIMITED is INR ₹ 12.0 Cr.
The registered address of CONCEPT PHARMACEUTICALS LIMITED is 801-B, HUBTOWN SOLARIS, N.S. PHADKE MARG, OFF. TELI GALLI, NEAR ANDHERI FLYOVER, ANDHERI (E) MUMBAI Mumbai City Maharashtra - 400069
The CIN number of CONCEPT PHARMACEUTICALS LIMITED is U24239MH1979PLC021126.
Expand
Delete
Collapse
See
details
